封面
市場調查報告書
商品編碼
1196846

胃腸病門診手術中心市場——增長、趨勢、COVID-19 影響和預測 (2023-2028)

Gastroenterology Ambulatory Surgery Center Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

胃腸病門診手術中心市場預計在預測期內(2022 年至 2027 年)的複合年增長率為 7%。

COVID-19 大流行似乎對大流行期間的市場增長產生了負面影響。 這主要是由於世界各地突然關閉,導致勞動力和員工短缺,以及僅優先處理緊急情況,這對市場增長產生了負面影響。 例如,2020 年 4 月,醫療保險和醫療補助服務中心宣布,它將建議在與醫學協會和協會的分階段框架合作中推遲非必要的手術和其他程序。 因此,在 COVID-19 大流行期間強制取消或推遲擇期手術等運營限制對市場增長產生了負面影響。 然而,在大流行後時期,這些嚴格的限制有所放鬆,患者的湧入逐漸增加,為市場參與者提供了有利可圖的機會。

胃腸道疾病發病率增加等因素是促進市場增長的主要因素。 例如,2020 年發表在《肛門、直腸和結腸雜誌》上的一項調查表明,日本約有 18 萬潰瘍性結腸炎患者。 此外,在拉丁美洲,新興工業化地區的發病率和患病率正在增加。 根據發表在 Therapeutic Advances in Gastroenterology Journal 2020 上的一項研究,拉丁美洲的潰瘍性結腸炎 (UC) 發病率為 0.04-8.00/100,000,患病率為 0.23-76.1/100,000。我來了。 研究表明,各種胃腸道疾病的患病率不斷上升,預計將推動市場增長。

此外,從醫院轉向門診手術中心的偏好也有望推動市場增長。 例如,根據 Medicare Payments Advisory Board 和 VMG Health Data 於 2021 年 6 月發布的數據,在過去十年中,門診手術中心的門診手術量有所增加。 其他驅動因素包括胃腸道疾病的手術干預和住院治療增加,以及生物製藥公司對研發的投資增加。 例如,截至 2022 年 8 月,根據國家臨床試驗 (NCT) 註冊處的數據,大約有 35,967 項正在進行的與胃腸道疾病相關的臨床試驗處於不同的發展階段。 這些研究的積極結果可能會在預測期內為增加胃腸病門診手術中心創造新的機會。

因此,由於上述因素,胃腸病門診手術中心有望在預測期內實現增長。

胃腸病門診手術中心市場趨勢

在胃腸門診手術中心市場,獨立細分市場有望佔據主要市場份額

預計在預測期內,自我維持的部分將主導市場增長。 獨立擁有的部分主要由醫生擁有的門診手術中心組成,由於對臨床環境和提供給患者的護理質量的最大專業控制,預計將佔最大份額。 這使醫生可以在一個環境中專注於少數程序。 門診內窺鏡檢查服務中心是獨立的設施,旨在執行低成本的胃腸道手術。 這種獨立設施的有益特性增加了患者的需求,並使製造商能夠實施各種營銷策略以促進市場增長。 據報導,潰瘍性結腸炎(UC)的發病率和患病率在新興工業化地區正在增加。 根據 2020 年 7 月發表的題為“拉丁美洲潰瘍性結腸炎流行病學和負擔回顧”的研究報告,拉丁美洲潰瘍性結腸炎 (UC) 的發病率在 0.04 到 8.00/100,000 之間。已發現患病率範圍從 0.23 到 76.1/100,000。 因此,調查和研究表明潰瘍性結腸炎的發病率和患病率有所增加,從而產生了對該細分市場的需求。

鑑於這些因素,該行業有望在預測期內實現增長。

預計北美將佔據很大的市場份額,並且預計在預測期內也會如此。

由於美國胃腸道問題的高發率和門診手術中心的廣泛採用,預計美國將引領全球市場。 例如,根據美國國家糖尿病、消化和腎臟疾病研究所 (NIDDK) 於 2020 年發表的一項研究,美國每年有 60 至 7000 萬人患有消化系統疾病。 此外,該地區門診手術中心的強大存在也有助於市場增長。 例如,2020 年 Medicare Payments Advisory Board 發布的數據顯示,美國有 9280 多家活躍的門診手術中心。 此外,主要市場參與者的出現和產品開發的先進技術預計將使該地區佔據主導地位。

同樣,推出創新產品以滿足日益增長的胃腸門診手術中心服務需求。 例如,2020 年 1 月,賓得醫療獲得美國食品和藥物管理局 (FDA) 510(K) 批准的 Imagina 內窺鏡系統,這是一種革命性的內窺鏡平台,用於門診手術中心的胃腸道 (GI) 程序。宣布已收購 此外,不斷增加的研發活動和良好的醫療保健基礎設施正在顯著推動該地區的整體市場增長。

胃腸病門診手術中心市場的競爭對手分析

胃腸病門診手術中心市場分散且競爭激烈,由幾家主要參與者組成。 從市場份額的角度來看,一些主要參與者主導著市場。 目前主導市場的一些公司是 Alpha Surgery Centers, LLC, Becton, Dixon and Company, Hill-Rom Holdings, GE Healthcare, Koninklijke Phillips NV, Cook Medical, Medtronic, Stomach Health LLC, Ohio Gastroenterology. Group Inc., Ontario高級外科中心、全民健康服務公司等。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 消化系統疾病增加
    • 越來越偏愛門診服務
  • 市場製約因素
    • 監管不確定性
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模:100 萬美元)

  • 按服務
    • 診斷服務
    • 外科服務
  • 由所有者
    • 醫院系統
    • 獨立
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Alfa Surgery Center, LLC
    • Becton, Dickison and company
    • Hill-Rom Holdings
    • GE healthacre
    • Koninklijke PhilipsN.V
    • Medtronic
    • Gastro Health LLC
    • Ohio Gastroeneterology Group Inc
    • Ontario Advanced Surgery Center
    • Universal Health Services Inc

第7章 市場機會今後動向

簡介目錄
Product Code: 90546

The Gastroenterology Ambulatory Surgery Center Market is projected to register a CAGR of 7% during the forecast period (2022-2027).

The COVID-19 pandemic seemed to negatively impact the market's growth during the pandemic period. This factor is mainly due to the sudden imposition of lockdowns across the globe, which resulted in a lack of workforce & staff-also, prioritizing only the emergency cases negatively impacted the market's growth. For instance, in April 2020, the Centers for Medicare & Medicaid Services announced recommendations for postponing non-essential surgeries and other procedures with the help of a tiered framework collaboration with medical societies and associations. Thus, operational restrictions such as mandates to stop or postpone elective surgeries during the COVID-19 pandemic negatively impacted the market's growth. However, the relaxations of such strict restrictions during the post-pandemic period provided lucrative opportunities for the market players as the patient influx will increase gradually.

The factors such as growing incidences of gastrointestinal disorders are the major factors contributing to the market's growth. For instance, a research study published in the Journal of Anus, Rectum, and Colon in 2020 showed around 180,000 patients with ulcerative colitis in Japan. In addition, the incidence and prevalence in Latin America have been rising in newly industrialized regions. According to a research study published in Therapeutic Advances in Gastroenterology Journal 2020, the incidence and prevalence of ulcerative colitis (UC) in Latin America were between 0.04 to 8.00/100,000 and 0.23 to 76.1/100,000, respectively. Research studies showing the increasing prevalence of various gastrointestinal disorders are expected to drive the market's growth.

Moreover, shifting preference toward ambulatory surgical centers from hospitals is also expected to boost the market's growth. For instance, according to the Medicare Payment Advisory Commission and VMG Health Data published in June 2021, the outpatient surgical volume in ambulatory surgical centers has increased over the last decade. Other driving factors include the rising surgical treatments and hospitalizations due to GI diseases and increasing R&D investments by biopharmaceutical companies. For instance, as of August 2022, there were around 35967 ongoing clinical trials related to gastrointestinal diseases across different phases of development, as per the National Clinical Trial (NCT) registry. The positive outcomes from these studies can create new opportunities for an increase in gastroenterology ambulatory surgery center over the forecast period.

Thus, due to the abovementioned factors, the gastroenterology ambulatory surgical center is expected to grow during the forecast period.

Gastroenterology Ambulatory Surgery Center Market Trends

The Freestanding Segment is Expected to Hold a Major Market Share in the Gastroenterology Ambulatory Surgery Center Market

The freestanding segment is expected to hold a dominating share in the growth of the market during the forecast period. The freestanding ownership segment, which mainly comprises physician-owned ambulatory surgery centers, is expected to account for the maximum share owing to maximum professional control over the clinical environment and quality of care delivered to patients. It allows the physicians to focus on a small number of procedures in a single setting. Endoscopic Ambulatory Service Centers are freestanding facilities designed to carry out gastrointestinal procedures at a low cost. Such beneficial characteristics of the freestanding ownership segment led to the increasing demand for the same among the patients, which allowed the manufacturers to implement various market strategies for market growth. In addition, the incidence and prevalence of ulcerative colitis (UC) have been reported to be rising in newly industrialized regions. According to a research study published in July 2020 titled 'Review of the Epidemiology and Burden of Ulcerative Colitis in Latin America', the incidence and prevalence of ulcerative colitis (UC) in Latin America were between 0.04 to 8.00/100,000 and 0.23 to 76.1/100,000. Therefore, the research and studies show the increasing incidence and prevalence of the Ulcerative Colitis condition, and this is generating demand for the segment.

Thus due to these factors, the studied segment is expected to grow during the forecast period.

North America is Expected to Hold a Significant Share in the Market and is expected to do the Same in the Forecast Period.

The United States is expected to command the global market due to the high incidence of Gastroenterology problems and the high adoption rate of ambulatory surgical centers. For instance, According to the study published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in 2020, 60 to 70 million people suffer from gastrointestinal diseases every year in the United States. Additionally, the strong presence of ambulatory surgical centers in the region contributes to the market's growth. For instance, according to the data published by the Medicare Payment Advisory Commission in 2020, the number of active ambulatory surgical centers in the United States is more than 9,280. Moreover, the presence of major market players and advanced technologies for product development is expected to mark this region with dominating share.

Similarly, the innovative product launches to meet the growing demand for gastroenterology ambulatory surgical center services. For instance, in January 2020, Pentax Medical announced that it had received United States Food and Administration (FDA) 510 (K) clearance for its Imagina Endoscopy System, an innovative endoscopy platform for gastrointestinal (GI) procedures at ambulatory surgery centers. Additionally, an increase in research and development activities and favorable healthcare infrastructure are fueling the growth of the overall regional market to a large extent.

Gastroenterology Ambulatory Surgery Center Market Competitor Analysis

The Gastroenterology Ambulatory Surgery Center Market is fragmented and competitive and consists of several major players. In terms of market share, a few major players dominate the market. Some of the companies which are currently dominating the market are Alfa Surgery Center, LLC, Becton, Dickison and Company, Hill- Rom Holdings, GE Healthcare, Koninklijke Philips N.V, Cook Medical, Medtronic, Gastro Health LLC, Ohio Gastroenterology Group Inc, Ontario Advanced Surgery Center, Universal Health Services Inc., and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing incidences of gastrointestinal diorders
    • 4.2.2 Rising preferences for ambulatory services
  • 4.3 Market Restraints
    • 4.3.1 Regulatory uncertainaties
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Services
    • 5.1.1 Diagnostic Services
    • 5.1.2 Surgical Services
  • 5.2 By Ownership
    • 5.2.1 Hospital-Affiliated
    • 5.2.2 Freestanding
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alfa Surgery Center, LLC
    • 6.1.2 Becton, Dickison and company
    • 6.1.3 Hill-Rom Holdings
    • 6.1.4 GE healthacre
    • 6.1.5 Koninklijke PhilipsN.V
    • 6.1.6 Medtronic
    • 6.1.7 Gastro Health LLC
    • 6.1.8 Ohio Gastroeneterology Group Inc
    • 6.1.9 Ontario Advanced Surgery Center
    • 6.1.10 Universal Health Services Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS